0001213900-21-053585.txt : 20211019 0001213900-21-053585.hdr.sgml : 20211019 20211019182222 ACCESSION NUMBER: 0001213900-21-053585 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211018 FILED AS OF DATE: 20211019 DATE AS OF CHANGE: 20211019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HSU ERIC C CENTRAL INDEX KEY: 0001817867 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 211332179 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml X0306 4 2021-10-18 0 0001728328 InMed Pharmaceuticals Inc. INM 0001817867 HSU ERIC C C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 0 1 0 0 Sr. VP, Pre-Clinical Res/Dev Employee Stock Option (Right to Buy) 1.40 2021-10-18 4 A 0 35000 0.00 A 2026-10-17 Common shares 35000 116969 D The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant. /s/ Bruce Colwill, attorney-in-fact for Mr. Eric C. Hsu 2021-10-19